107 related articles for article (PubMed ID: 2234777)
21. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
Chabot MC; Wykle RL; Modest EJ; Daniel LW
Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333
[TBL] [Abstract][Full Text] [Related]
22. Elimination of leukemic cells by the combined use of ether lipids in vitro.
Okamoto S; Olson AC; Vogler WR
Cancer Res; 1987 May; 47(10):2599-603. PubMed ID: 3471316
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species.
Wagner BA; Buettner GR; Oberley LW; Burns CP
Cancer Res; 1998 Jul; 58(13):2809-16. PubMed ID: 9661895
[TBL] [Abstract][Full Text] [Related]
24. Membrane lipid modification and sensitivity of leukemic cells to the thioether lipid analogue BM 41.440.
Petersen ES; Kelley EE; Modest EJ; Burns CP
Cancer Res; 1992 Nov; 52(22):6263-9. PubMed ID: 1423272
[TBL] [Abstract][Full Text] [Related]
25. In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts.
Mollinedo F; de la Iglesia-Vicente J; Gajate C; Estella-Hermoso de Mendoza A; Villa-Pulgarin JA; de Frias M; Roué G; Gil J; Colomer D; Campanero MA; Blanco-Prieto MJ
Clin Cancer Res; 2010 Apr; 16(7):2046-54. PubMed ID: 20233887
[TBL] [Abstract][Full Text] [Related]
26. Is metabolism an important arbiter of anticancer activity of ether lipids? Metabolism of SRI 62-834 and hexadecylphosphocholine by [31P]-NMR spectroscopy and comparison of their cytotoxicities with those of their metabolites.
Bishop FE; Dive C; Freeman S; Gescher A
Cancer Chemother Pharmacol; 1992; 31(2):85-92. PubMed ID: 1451237
[TBL] [Abstract][Full Text] [Related]
27. Ether-linked phosphoglyceride content of human leukemia cells.
Chabot MC; Greene DG; Brockschmidt JK; Capizzi RL; Wykle RL
Cancer Res; 1990 Nov; 50(22):7174-8. PubMed ID: 2224852
[TBL] [Abstract][Full Text] [Related]
28. Increased ether lipid cytotoxicity by reducing membrane cholesterol content.
Diomede L; Piovani B; Modest EJ; Noseda A; Salmona M
Int J Cancer; 1991 Sep; 49(3):409-13. PubMed ID: 1917140
[TBL] [Abstract][Full Text] [Related]
29. Autologous bone marrow transplantation with alkyl-lysophospholipid-purged marrow.
Vogler WR; Berdel WE
J Hematother; 1993; 2(1):93-102. PubMed ID: 7921970
[TBL] [Abstract][Full Text] [Related]
30. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
[TBL] [Abstract][Full Text] [Related]
31. Neoplastic cell inhibition with new ether lipid analogs.
Noseda A; Berens ME; Piantadosi C; Modest EJ
Lipids; 1987 Nov; 22(11):878-83. PubMed ID: 3444381
[TBL] [Abstract][Full Text] [Related]
32. Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62-834 in EMT6 mouse mammary tumor and HL-60 human promyelocytic leukemia cells.
Dive C; Watson JV; Workman P
Cancer Res; 1991 Feb; 51(3):799-806. PubMed ID: 1988120
[TBL] [Abstract][Full Text] [Related]
33. Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines.
Civoli F; Daniel LW
Cancer Chemother Pharmacol; 1998; 42(4):319-26. PubMed ID: 9744778
[TBL] [Abstract][Full Text] [Related]
34. Lymphokine-activated killer (LAK) cell purging of bone marrow.
Cramer DV; Long GS
Prog Clin Biol Res; 1990; 333():125-35; discussion 136-7. PubMed ID: 2308977
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxic effects of hexadecylphosphocholine in neoplastic cell lines including drug-resistant sublines in vitro.
Danhauser-Riedl S; Himmelmann A; Steinhauser G; Busch R; Vogler WR; Rastetter J; Berdel WE
J Lipid Mediat; 1990; 2(5):271-80. PubMed ID: 2133272
[TBL] [Abstract][Full Text] [Related]
36. Effect of cell density on cytotoxicity of ether lipid analogues in variants of B16 murine melanoma.
Trulla LL; Magistrelli A; Salmona M; Tacconi MT
Lipids; 1993 May; 28(5):403-6. PubMed ID: 8316047
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of the spin-labeled derivative of an ether-linked phospholipid possessing high antineoplastic activity.
Joseph J; Shih CC; Lai CS
Chem Phys Lipids; 1991; 58(1-2):19-26. PubMed ID: 1657423
[TBL] [Abstract][Full Text] [Related]
38. Cyclic oxygen analogues of alkyl-lysophospholipids. Synthesis and neoplastic cell growth inhibitory properties.
Houlihan WJ; Lee ML; Munder PG; Winslow CM; Cheon SH; D'Aries FJ; DeLillo AK; Jaeggi CS; Mason RB; Parrino VA
J Lipid Mediat; 1990; 2(5):295-307. PubMed ID: 2133273
[TBL] [Abstract][Full Text] [Related]
39. Cytokinetic and morphologic differences in ovarian cancer cells treated with ET-18-OCH3 and the DNA-interacting agent, etoposide.
Fujiwara K; Koike H; Ohishi Y; Shirafuji H; Kohno I; Modest EJ; Kataoka S
Anticancer Res; 1997; 17(3C):2159-67. PubMed ID: 9216681
[TBL] [Abstract][Full Text] [Related]
40. Effects of structural modifications of ether lipids on antiproliferative activity against human glioma cell lines.
Berens ME; Bar-Shira E; Rosenblum ML; Piantadosi C; Modest EJ
Anticancer Res; 1993; 13(2):401-5. PubMed ID: 8517654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
